References
- Lin CH, Chen KH, Chen CM, et al. Risk factors for osteoporosis in male patients with chronic obstructive pulmonary disease in Taiwan. PeerJ. 2018 Jan;12(6):e4232.
- Lin CW, Chen YY, Chen YJ, et al. Prevalence, risk factors and health-related quality of life of osteoporosis in patients with COPD at a community hospital in Taiwan. Int J Chron Obstruct Pulmon Dis. 2015 Jul;29(10):1493–1500.
- Yamauchi Y, Yasunaga H, Sakamoto Y, et al. Mortality associated with bone fractures in COPD patients. Int J Chron Obstruct Pulmon Dis. 2016 Sep;11(11):2335–2340.
- Unnanuntana A, Saleh A, Mensah KA, et al. Atypical femoral fractures: what do we know about them? J Bone Joint Surg Am. 2013 Jan 16;2(95):e81–13.
- Sato H, Kondo N, Wada Y, et al. The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates. Osteoporos Int. 2016 Mar;27(3):1217–1225.
- Koh A, Guerado E, Giannoudis PV. Atypical femoral fractures related to bisphosphonate treatment: issues and controversies related to their surgical management. Bone Joint J.. 2017 Mar;99-B(3):295–302.
- Favinger JL, Hippe D, Ha AS. Long-term radiographic follow-up of bisphosphonate-associated atypical femur fractures. Skeletal Radiol. 2016 May;45(5):627–633.
- Oh CW, Oh JK, Park KC, et al. Prophylactic nailing of incomplete atypical femoral fractures. ScientificWorldJournal. 2013;2013:450148.
- Shane E, Burr D, Abrahamsen B, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014 Jan;29(1):1–23.
- Mahjoub Z, Jean S, Leclerc JT, et al. Incidence and characteristics of atypical femoral fractures, clinical and geometrical data. J Bone Miner Res. 2016 Apr;31(4):767–776.
- Hagen JE, Miller AN, Ott SM, et al. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry. J Bone Joint Surg Am. 2014 Nov 19;96(22):1905–1909.
- Villiers J, Clark DW, Jeswani T, et al. An atraumatic femoral fracture in a patient with rheumatoid arthritis and osteoporosis treated with denosumab. Case Rep Rheumatol. 2013;2013:249872.
- Drampalos E, Skarpas G, Barbounakis N, et al. Atypical femoral fractures bilaterally in a patient receiving denosumab. Acta Orthop. 2014 Feb;85(1):3–5.
- Ramchand SK, Chiang CY, Zebaze RM, et al. Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report. Osteoporos Int. 2016 Feb;27(2):821–825.
- Selga J, Nuñez JH, Minguell J, et al. Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review. Osteoporos Int. 2016 Feb;27(2):827–832.